皮膚糸状菌爪真菌症（DO）：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 8
3 Market Outlook 9
3.1 United States 9
3.1.1 Forecast 9
3.1.2 Key Events 13
3.1.3 Drivers and Barriers 14
4 Current and Future Players 17
4.1 Overview 17
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 20
4.3.1 Valeant Pharmaceuticals International 20
4.3.2 Topica Pharmaceuticals 23
4.3.3 Anacor Pharmaceuticals 25
4.4 Late-Stage Competition 28
4.4.1 Celtic Pharmaceutical Holdings 28
4.4.2 Palau Pharma 29
4.5 Early-Stage Competition 30
4.5.1 Merck 30
4.5.2 Apricus Biosciences 30
5 Appendix 32
5.1 Bibliography 32
5.2 Abbreviations 33
5.3 Methodology 34
5.4 Forecasting Methodology 34
5.4.1 Diagnosed DO patients 34
5.4.2 Percent Drug-Treated Patients 35
5.4.3 Drugs Included in Each Therapeutic Class 35
5.4.4 Launch and Patent Expiry Dates 35
5.4.5 General Pricing Assumptions 36
5.4.6 Individual Drug Assumptions 36
5.4.7 Pricing of Pipeline Agents 38
5.5 Physicians and Specialists Included in this Study 40
5.6 About the Authors 41
5.6.1 Author 41
5.6.2 Reviewer 41
5.6.3 Epidemiologist 42
5.6.4 Global Head of Healthcare 42
5.7 About GlobalData 43
5.8 Disclaimer 43